Musunuru, Hima Bindu <br/><br/>
Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  12 2018 
 - 1438-1447 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2018.07.2005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Dose Fractionation, Radiation<br/>Endpoint Determination<br/>Humans<br/>Lymphatic Irradiation--adverse effects<br/>Male<br/>Middle Aged<br/>Prostatic Neoplasms--radiotherapy<br/>Quality of Life<br/>Radiosurgery--adverse effects<br/>Risk<br/>Safety<br/>Time Factors